These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
336 related items for PubMed ID: 17179401
1. Cytotoxicity of iodinated and gadolinium-based contrast agents in renal tubular cells at angiographic concentrations: in vitro study. Heinrich MC, Kuhlmann MK, Kohlbacher S, Scheer M, Grgic A, Heckmann MB, Uder M. Radiology; 2007 Feb; 242(2):425-34. PubMed ID: 17179401 [Abstract] [Full Text] [Related]
2. Reversibility and time-dependency of contrast medium induced inhibition of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) conversion in renal proximal tubular cells in vitro: comparison of a monomeric and a dimeric nonionic iodinated contrast medium. Heinrich M, Scheer M, Heckmann M, Bautz W, Uder M. Invest Radiol; 2007 Nov; 42(11):732-8. PubMed ID: 18030195 [Abstract] [Full Text] [Related]
3. Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro. Heinrich MC, Kuhlmann MK, Grgic A, Heckmann M, Kramann B, Uder M. Radiology; 2005 Jun; 235(3):843-9. PubMed ID: 15845795 [Abstract] [Full Text] [Related]
8. Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T. Attenberger UI, Runge VM, Jackson CB, Baumann S, Birkemeier K, Michaely HJ, Schoenberg SO, Reiser MF, Wintersperger BJ. Invest Radiol; 2009 May; 44(5):251-6. PubMed ID: 19550376 [Abstract] [Full Text] [Related]
10. Renal time-resolved MR angiography: quantitative comparison of gadobenate dimeglumine and gadopentetate dimeglumine with different doses. Völk M, Strotzer M, Lenhart M, Seitz J, Manke C, Feuerbach S, Link J. Radiology; 2001 Aug; 220(2):484-8. PubMed ID: 11477257 [Abstract] [Full Text] [Related]
11. Skin gadolinium following use of MR contrast agents in a rat model of nephrogenic systemic fibrosis. Haylor J, Schroeder J, Wagner B, Nutter F, Jestin G, Idée JM, Morcos S. Radiology; 2012 Apr; 263(1):107-16. PubMed ID: 22344402 [Abstract] [Full Text] [Related]
12. Dynamic and static magnetic resonance angiography of the supra-aortic vessels at 3.0 T: intraindividual comparison of gadobutrol, gadobenate dimeglumine, and gadoterate meglumine at equimolar dose. Kramer JH, Arnoldi E, François CJ, Wentland AL, Nikolaou K, Wintersperger BJ, Grist TM. Invest Radiol; 2013 Mar; 48(3):121-8. PubMed ID: 23211552 [Abstract] [Full Text] [Related]
13. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine. Bauner KU, Reiser MF, Huber AM. Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911 [Abstract] [Full Text] [Related]
18. Gadobenate dimeglumine (MultiHance) in MR angiography: an in-vitro phantom comparison with gadopentetate dimeglumine (Magnevist) at different concentrations. Johansson L, Kirchin MA, Ahlström H. Acta Radiol; 2012 Dec 01; 53(10):1112-7. PubMed ID: 23081961 [Abstract] [Full Text] [Related]
20. Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine. Knopp MV, Bourne MW, Sardanelli F, Wasser MN, Bonomo L, Boetes C, Müller-Schimpfle M, Hall-Craggs MA, Hamm B, Orlacchio A, Bartolozzi C, Kessler M, Fischer U, Schneider G, Oudkerk M, Teh WL, Gehl HB, Salerio I, Pirovano G, La Noce A, Kirchin MA, Spinazzi A. AJR Am J Roentgenol; 2003 Sep 01; 181(3):663-76. PubMed ID: 12933457 [Abstract] [Full Text] [Related] Page: [Next] [New Search]